Morphogenetic Engineering is an emerging interdisciplinary field that combines principles from biology, engineering, and computer science to design and control the self-organization of living systems for specific purposes. It seeks to harness the intrinsic capabilities of biological organisms to generate complex structures, patterns, and functions through the manipulation of morphogenetic processes. At its core, morphogenetic engineering focuses on understanding the molecular, cellular, and mechanical mechanisms underlying morphogenesis—the process by which organisms develop their shape, form, and structure during embryonic development and tissue regeneration. By elucidating the principles governing morphogenetic processes, researchers aim to engineer and guide the self-assembly of biological structures with desired shapes, sizes, and functions. One key aspect of morphogenetic engineering is the use of synthetic biology approaches to design and engineer genetic circuits, signalling pathways, and gene regulatory networks that control cell fate determination, tissue patterning, and morphogen gradients in living organisms. Synthetic morphogenetic systems can be engineered to respond to external stimuli, such as light, chemicals, or mechanical cues, enabling dynamic control over morphogenesis and tissue development. Morphogenetic engineering also draws inspiration from developmental biology and evolutionary biology to understand how natural systems achieve complex morphogenetic outcomes through the interaction of genetic, environmental, and stochastic factors.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States